IIM
GILD icon

IFC & Insurance Marketing’s Gilead Sciences GILD Stock Holding History

IFC & Insurance Marketing’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-36
Closed -$4K – 285
2025
Q4 		$4K Buy
+36
New +$4.38K ﹤0.01% 545

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

IFC & Insurance Marketing's GILD Position: Q1 2026 in Review

IFC & Insurance Marketing sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 36 shares — an estimated $4K sold.

IFC & Insurance Marketing first reported a position in GILD in Q4 2025 and held it in 1 quarter. The position peaked at $4K in Q4 2025. 2,320 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • IFC & Insurance Marketing reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
  • IFC & Insurance Marketing sold 36 Gilead Sciences shares in Q1 2026, an estimated $4K.
  • IFC & Insurance Marketing first reported a position in Gilead Sciences in Q4 2025 and held it in 1 quarter.
  • IFC & Insurance Marketing's Gilead Sciences position peaked at $4K in Q4 2025.
  • 2,320 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on IFC & Insurance Marketing's 13F filing for Q1 2026, filed 17 Apr 2026.